Related references
Note: Only part of the references are listed.Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells
Mitsunobu Takeda et al.
CANCER RESEARCH (2019)
Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors
Taito Esaki et al.
CANCER SCIENCE (2019)
Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination
Shelby Lennon et al.
CLINICAL CANCER RESEARCH (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla et al.
WORLD JOURNAL OF ONCOLOGY (2019)
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
Shukui Qin et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Vitamin D Supplementation is a Promising Therapy for Pancreatic Ductal Adenocarcinoma in Conjunction with Current Chemoradiation Therapy
Yosuke Mukai et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma
Mohamed Bouattour et al.
HEPATOLOGY (2018)
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
Conor A. Bradley et al.
Nature Reviews Clinical Oncology (2018)
Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models
Yingchao Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial
Daniel V. T. Catenacci et al.
LANCET ONCOLOGY (2017)
Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma The METGastric Randomized Clinical Trial
Manish A. Shah et al.
JAMA ONCOLOGY (2017)
MicroRNA-181b-5p, ETS1, and the c-Met pathway exacerbate the prognosis of pancreatic ductal adenocarcinoma after radiation therapy
Hideo Tomihara et al.
CANCER SCIENCE (2017)
Gastroenterological surgery in Japan: The past, the present and the future
Hugh Colvin et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2017)
Preoperative Gemcitabine-based Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer Impact of Venous and Arterial Involvement Status on Surgical Outcome and Pattern of Recurrence
Hidenori Takahashi et al.
ANNALS OF SURGERY (2016)
Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice
Lena Seifert et al.
GASTROENTEROLOGY (2016)
Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model
Franziska Brandes et al.
BMC CANCER (2015)
Susceptibility of pancreatic cancer stem cells to reprogramming
Kozo Noguchi et al.
CANCER SCIENCE (2015)
AKT and MET signalling mediates antiapoptotic radioresistance in head neck cancer cell lines
Tobias Ettl et al.
ORAL ONCOLOGY (2015)
c-Met signaling in the development of tumorigenesis and chemoresistance: Potential applications in pancreatic cancer
Daniel Delitto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Overexpression of c-Met increases the tumor invasion of human prostate LNCaP cancer cells in vitro and in vivo
Yili Han et al.
ONCOLOGY LETTERS (2014)
Modulation of c-Met signaling and cellular sensitivity to radiation Potential Implications for Therapy
Vikas Bhardwaj et al.
CANCER (2013)
The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells
Andrea Balogh et al.
INFLAMMATION RESEARCH (2013)
Targeting the Hepatocyte Growth Factor-cMET Axis in Cancer Therapy
George R. Blumenschein et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis
C. H. Chou et al.
ONCOGENE (2012)
A Novel Kinase Inhibitor, INCB28060, Blocks c-MET-Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3
Xiangdong Liu et al.
CLINICAL CANCER RESEARCH (2011)
c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
Chenwei Li et al.
GASTROENTEROLOGY (2011)
Head neck squamous cell carcinoma c-Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis
Shuyang Sun et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer
Francesca De Bacco et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
Feasibility and Efficacy of Combination Therapy With Preoperative Full-Dose Gemcitabine, Concurrent Three-Dimensional Conformal Radiation, Surgery, and Postoperative Liver Perfusion Chemotherapy for T3-Pancreatic Cancer
Hiroaki Ohigashi et al.
ANNALS OF SURGERY (2009)
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head
Douglas B. Evans et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: Implications for radiotherapy of hepatocellular carcinoma
YL Chung et al.
CLINICAL CANCER RESEARCH (2006)
Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: Radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor
EK Rofstad et al.
CANCER RESEARCH (2004)
Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and map kinase activity in pancreatic cancer cells
LW Qian et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells
G Bowers et al.
ONCOGENE (2001)
Share Paper
